🔎 Trials Near Me

홈 › 유방암 › 텍사스 › San Antonio

TX San Antonio의 유방암 임상 시험

유방암 관련 연구 47개가 San Antonio 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

피험자 모집 중1/2상
  • Research Site, San Antonio
18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05417594

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • START - San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06784193

A Study of PHST001 in Advanced Solid Tumors

피험자 모집 중1상
  • START Center for Cancer Research - San Antonio, San Antonio
  • University of Texas (UT) Health, San Antonio
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

피험자 모집 중1/2상
  • New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

피험자 모집 중관찰 연구건강한 지원자 환영
  • Audie L Murphy VA Hospital, San Antonio
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

피험자 모집 중2상
  • UT Health San Antonio, Mays Cancer Center, San Antonio
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07102381

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

피험자 모집 중1상
  • University of Texas San Antonio (UTSA), San Antonio
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06625775

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

피험자 모집 중1상
  • NEXT Oncology - PARENT, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07360314

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

피험자 모집 중1상
  • Next Oncology, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06120283

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

피험자 모집 중3상
  • Mays Cancer Center ( Site 0049), San Antonio
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

피험자 모집 중3상
  • Texas Oncology - San Antonio ( Site 8002), San Antonio
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

피험자 모집 중3상
  • Texas Oncology - San Antonio ( Site 8004), San Antonio
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

피험자 모집 중3상
  • Clinical Trial Site, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

피험자 모집 중3상
  • Texas Oncology - San Antonio Medical Center, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

피험자 모집 중1상
  • South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
18세 이상 · 여성 · 2026. 9. 21. 업데이트됨 · NCT07524855

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

피험자 모집 중1/2상
  • South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06827236

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

피험자 모집 중1/2상
  • START Center for Cancer Research, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

피험자 모집 중3상
  • Mays Cancer Center, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

피험자 모집 중1상
  • START - San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • NEXT Oncology, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

피험자 모집 중1상
  • South Texas Accelerated Research Therapeutics (START), San Antonio
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT05307705

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

피험자 모집 중3상
  • Texas Oncology-San Antonio Cancer Care, San Antonio
  • Texas Oncology - San Antonio Northeast, San Antonio
  • Texas Oncology - San Antonio Stone Oak, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

피험자 모집 중3상
  • University of Texas Health Science Center at San Antonio, San Antonio
18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

피험자 모집 중2상
  • University of Texas Health Science Center at San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07076485

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

피험자 모집 중1상
  • South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07029399

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

피험자 모집 중1상
  • START San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

피험자 모집 중1상
  • UT Health San Antonio - MD Anderson Cancer Center, San Antonio
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

피험자 모집 중3상
  • The University of Texas Health Sciences Center at San Antonio - Mays Cancer Center, San Antonio
  • Texas Oncology - San Antonio Medical Center, San Antonio
18세 ~ 100세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT05232916

IDOV-Immune for Advanced Solid Tumors

피험자 모집 중1상
  • South Texas Accelerated Research Therapeutics, San Antonio
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06910657

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

피험자 모집 중1/2상
  • START, San Antonio
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07288359

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

피험자 모집 중1상
  • NEXT San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07524322

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • START San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07318805

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • START San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

피험자 모집 중1/2상
  • START San Antonio, San Antonio
  • Texas Oncology - San Aantonio, San Antonio
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT07558733

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • START, San Antonio
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT06993844

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

피험자 모집 중1상
  • The University of Texas Health Science Center at San Antonio, San Antonio
18세 ~ 99세 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05029999

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

피험자 모집 중3상
  • Mays Cancer Center, San Antonio
18세 이상 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT06757634

Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer

피험자 모집 중
  • Mays Cancer Center, UT Health San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 5. 8. 업데이트됨 · NCT07574671

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • NEXT Oncology, San Antonio
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06239194

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

피험자 모집 중1상
  • NEXT Oncology San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 4. 7. 업데이트됨 · NCT07424547

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

피험자 모집 중2상
  • Texas Oncology- San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 3. 20. 업데이트됨 · NCT05748834

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

피험자 모집 중1/2상
  • Research Site, San Antonio
18세 이상 · 모든 성별 · 2026. 3. 2. 업데이트됨 · NCT06956690

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

피험자 모집 중1/2상
  • START San Antonio, San Antonio
18세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT07145255

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • Exelixis Clinical Site #3, San Antonio
18세 이상 · 모든 성별 · 2025. 9. 5. 업데이트됨 · NCT05932862

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

피험자 모집 중관찰 연구
  • Texas Oncology, PA - Metropolitan, San Antonio
  • Texas Oncology, PA - Northeast, San Antonio
  • UT Health Cancer Center, San Antonio
  • 외 2개
18세 이상 · 모든 성별 · 2025. 8. 20. 업데이트됨 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

피험자 모집 중2상
  • Texas Oncology PA (San Antonio), San Antonio
18세 이상 · 모든 성별 · 2025. 6. 19. 업데이트됨 · NCT06568692

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

피험자 모집 중1상
  • Biotheryx Investigative Site, San Antonio
18세 이상 · 모든 성별 · 2025. 6. 6. 업데이트됨 · NCT06515470

다른 도시의 유방암 시험

San Antonio의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.